Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect that heart and vessels such as coronary artery disease, stroke, hypertension and ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
March 13, 2026 — According to a new research study published by Vyansa Intelligence, the Cardiovascular Devices Market ...
March 19, 2026 — Endovascular Engineering, Inc. has announced that two abstracts related to the ENGULF study and the ...
March 19, 2026 — Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis ...
Feb. 9, 2026 —The International Cardio-Oncology Society has awarded University Hospitals in Cleveland, Ohio, with a ...
March 17, 2026 — Empassion Health, Inc. has announced a strategic partnership with Karoo Health Inc, America’s Cardiac ...
March 17, 2026 — Stern Cardiovascular and Atria Health have announced a strategic partnership that will accelerate ...
March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 10, 2026 — HeartHero has announced that its Premarket Approval (PMA) application for Elliot, the company’s ...
March 4, 2026 — Inflo Health has launched a comprehensive cardiology suite designed to address care management gaps ...
March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...
March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...
Feb. 27, 2026 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s CardioMEMS Hero device — a pulmonary ...
Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...
Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...
March 23, 2026